LATEST TWEETS - CURATED BY HASH FINANCE
StockTwits Trending Alert: Trading recent interest in KRYSTAL BIOTECH INC. COMMON STOCK $KRYS https://t.co/UfeewtcYsR
$KRYS $1.76B mc $XBI name following thru off mean reversion $100 / $50 level on above avg wkly volume. 10/40 wk SMA… https://t.co/GODR1cGEmF
Krystal Biotech Inc Shares Close the Week 23.5% Higher - Weekly Wrap https://t.co/msap2Gxabo $KRYS #stockmarket #kwhenfinance
$KRYS Trading Ideas | Awaiting Short signal. 71.43% Profitability based on 7 trades. Profit factor is 4.15. Learn m… https://t.co/807qxaK9ML
Rose Above Upper Bollinger Band today: $TFFP $KRYS ... https://t.co/AyIukUGmib
$KRYS Krystal Biotech looks for FDA approval for dystrophic epidermolysis bullosa treatment https://t.co/XeUm9GyTON via @Labiotech_eu
Krystal Biotech Inc $KRYS has submitted an FDA marketing application seeking approval of B-VEC (beremagene geperpa… https://t.co/jbQ2esZGRS
$KRYS in Uptrend: price may jump up because it broke its lower Bollinger Band on June 13, 2022. View odds for this… https://t.co/ieDgzxpK7t
Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B-VEC for the Treatment of Pa… https://t.co/nT3V1q0K4a
Wow this is a big change! $KRYS price moved above its 50-day Moving Average. #KrystalBiotech https://t.co/EohGnWZflh https://t.co/fF5tcTFJFp
How will this affect the market? $KRYS Stochastic Oscillator left the oversold zone. #KrystalBiotech… https://t.co/WMTEBQkkXF
Carbon Sciences just left stealth mode to develop parvovirus (PVV?) gene therapies for cystic fibrosis.
➡️ Larger… https://t.co/itlR71YRWJ
Good move so far got $krys leaps Jan 23 $70 and Jan 24 $110
👉 FBC Holding, Inc. $FBCD Set to Exhibit at California Market Fashion Week in Los Angeles https://t.co/1HmnueflBH https://t.co/BWwmOia7E5
yup $krys redosable gene therapy just submitted the BLA https://t.co/dFLvhGXt2Z
Krystal Biotech Files To Seek Approval For Skin Disease Candidate https://t.co/KoHdpCZhU9 $KRYS
$KRYS News Screener Alert: The price is up after the recent publication posted about 3 hours ago .… https://t.co/zBOCu9LlNr
Krystal Biotech Inc. has applied to the U.S. Food and Drug Administration for permission for one of its gene therap… https://t.co/pxHXAdtPmr
$KRYS Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B-VEC for the Treatment… https://t.co/L9V3j4zoYx
$KRYS: Krystal Biotech submits Biologics License Application to FDA seeking approval of B-VEC https://t.co/5i2uYKeRHY
$KRYS 8-K Krystal Biotech (22 Jun, 8:41am)
📰 Regulation FD Disclosure; Financial Statements and Exhibits… https://t.co/K7dBcnO1em
$KRYS Submits BLA for B-VEC for the Treatment of Patients with Dystrophic Epidermolysis Bullosa
Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B-VEC for the Treatment of Pa… https://t.co/6E1inI7cjH
$KRYS [15s. delayed]: Issued Press Release on June 22, 07:00:00: Krystal Biotech Submits Biologics License Applicat… https://t.co/eh6QA996ZH
$KRYS Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B-VEC for the Treatment… https://t.co/hhwxKnxmxM
$KRYS Krystal Biotech Submits Biologics License Application to U.S. FDA Seeking Approval of B-VEC for the Treatment… https://t.co/d5SKT249BX
